Q4 2024 Beiersdorf AG Earnings Call Transcript
Key Points
- Beiersdorf AG (BDRFF) achieved record net sales of EUR9.9 billion in 2024, with a strong organic sales growth of 6.5%.
- The company's EBIT margin improved by 50 basis points to 13.9%, demonstrating effective cost management and profitability.
- NIVEA, a key brand, delivered exceptional growth across all regions, with a notable 9% increase in sales, driven by innovations like LUMINOUS630.
- The Derma business, including Eucerin and Aquaphor, saw a double-digit sales growth of 10.6%, with Eucerin becoming the second EUR1 billion brand in the Consumer portfolio.
- Beiersdorf AG (BDRFF) is committed to sustainability, achieving a 25.3% reduction in GHG emissions and converting NIVEA cream tins to 80% recycled aluminum.
- The luxury brand La Prairie experienced a sales decline of 6.2% in 2024, primarily due to challenges in the Greater China ecosystem and travel retail market.
- The tesa division faced significant challenges with only a 1.9% organic sales growth, impacted by difficult market conditions in the chemical industry.
- Beiersdorf AG (BDRFF) anticipates a weaker Q1 2025 due to a strong prior year comparison and ongoing challenges in the luxury market.
- The company is undertaking a strategic inventory cleanup in China, which may temporarily impact sales performance in the first half of 2025.
- There is a potential impact from US tariffs, which could affect the company's cost structure and pricing strategies in the North American market.
Good morning, and welcome to Beiersdorf's 2024 full-year results presentation. It's great to have you with us today. I'm here with our CFO, Astrid Hermann; and our CEO, Vincent Warnery, who will walk you through our full-year and fourth-quarter results shortly. (Event Instructions)
And with that, I'd like to hand it over to Vincent.
Thank you, Christopher, and good morning to all of you. Thank you for joining our 2024 full-year results conference. Astrid and I have now the pleasure to walk you through our financial results and share an update on the significant progress we have made in implementing our Win With Care strategy. Moreover, we'll provide an outlook on our plans for 2025 and beyond. After that, the floor will be open for your questions.
Let's start by looking back on 2024. 2024 was yet another challenging year, marked by ongoing geopolitical instability and macroeconomic volatility
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
